2151 A ten years experience of the treatment of 207 uveal melanomas with 106 RU/106 RH applications
نویسندگان
چکیده
Methods: From lYYO-1993, 38 cases of unilutcrdl retinoblastoma were treated in National Cancer Center Hospital in Tokyo. Except for Y eyes with absolute glaucoma, suspicious extraocular extension or refusal of conservative therapy, all of them were treated conservatively. Ocular hypcrthetmia using Lagendijk’s applicator wwc combined with radiotherapy, selective t,, ophthalmic aaerial injection by balloon catheter or vitreous injection of a small amount of melphalan.
منابع مشابه
Ruthenium-106 brachytherapy for thick uveal melanoma: reappraisal of apex and base dose radiation and dose rate.
PURPOSE To evaluate the outcomes of ruthenium-106 ((106)Ru) brachytherapy in terms of radiation parameters in patients with thick uveal melanomas. MATERIAL AND METHODS Medical records of 51 patients with thick (thickness ≥ 7 mm and < 11 mm) uveal melanoma treated with (106)Ru brachytherapy during a ten-year period were reviewed. Radiation parameters, tumor regression, best corrected visual ac...
متن کاملCell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: an EORTC ocular oncology group study.
AIM To evaluate the cell proliferation activity in posterior uveal melanomas after Ru-106 brachytherapy. METHODS Eyes containing choroidal or ciliary body melanoma from seven ocular oncology centres, which were enucleated after first being treated by Ru-106 brachytherapy and which had enough melanoma tissue to enable histological assessment, were included. The 57 eligible specimens were divid...
متن کاملRuthenium-106 Brachytherapy for Uveal Melanomas – Preliminary Results: a Single Institutional Experience*
OBJECTIVE: To analyze the early response of uveal melanomas in patients treated with ruthenium-106 brachytherapy. MATERIALS AND METHODS: In the period between April 2002 and July 2003, 20 patients diagnosed with uveal melanoma were submitted to ruthenium-106 brachytherapy. The calculated dose delivered at the apex of the tumor ranged between 55 Gy and 100 Gy. Patients with lesions greater than ...
متن کاملبرآورد پارامترهای دوزیمتری پلاک های چشمی 106Ru/106Rh در براکی تراپی تومورهای ملانومای کوچک Uvea با استفاده از روش شبیه سازی مونت کارلو
Background and purpose: Concave eye applicators of Ru-106, a beta emitter source, have a lot of use in brachytherapy of intraocular tumors. This has led to the need of knowing the exact dose distribution caused by beta radiation to the tumor and its normal surrounding tissue. The purpose of this study was the 3D calculation of dose distribution for three Ru-106 plaques: CCA, CCB, and CGD in a h...
متن کاملBrachytherapy of Uveal Melanomas with Ruthenium-106 Plaques
Background: Brachytherapy is the most commonly used conservative treatment for the uveal melanoma. The aim of this study was to evaluate therapeutic results of Ruthenium-106 plaque brachytherapy in the management of localized uveal melanoma cases. Methods: We reviewed retrospectively the clinical records of all patients treated in our department for an uveal melanoma, undergoing Ruthenium-106 p...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Vision Research
دوره 35 شماره
صفحات -
تاریخ انتشار 1995